KPI-121

· Kala Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for KPI-121, covering 2019-04-17 to 2021-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of KPI-121 in Subjects With DED [Phase 3]